RecruitingNot ApplicableNCT05759780
OCT Vibrography for Biomechanical Properties of Tissues
A Study to Test the Potential of OCT Vibrography for Measuring Biomechanical Properties of Tissues
Sponsor
Massachusetts General Hospital
Enrollment
90 participants
Start Date
Aug 19, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The overall goal of this study is to develop OCT Vibrography (aka OCT elastography) as a novel tool for measuring biomechanical properties of human tissues in vivo.
Eligibility
Min Age: 18 YearsMax Age: 75 Years
Inclusion Criteria5
- Group 1:
- • Subjects with healthy eyes (age 18 - 75, N = 50)
- • Subjects with healthy skin (age 18 - 75, N = 10)
- • Subjects with healthy gingiva (age 18 - 75, N = 10)
- • Mild or moderate keratoconus subjects (age 18 - 40, N = 20)
Exclusion Criteria12
- Subjects with history of eye diseases, and previous eye surgeries.
- Subjects with diabetes, glaucoma family history
- Subjects allergic to anesthetic eyedrop, especially proparacaine
- Subjects with severe allergy
- Subjects who have difficulty biting
- Subjects who have recurrent corneal erosion
- Group 2:
- • Subjects with open cuts/sores on the skin, skin infection, or any contagious skin condition
- Group 3:
- • Subjects with open cuts/sores on the gingiva, gingiva infection, or any contagious gingiva condition
- Group 4:
- • Subjects with K-max above 60 diopters (Pentacam imaging) are excluded
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEOptical imaging of the tissues
OCT vibrography
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05759780
Related Trials
A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases
NCT074126911 location
Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
NCT063876541 location
NOVOSYN® Quick Versus MONOSYN® Quick Suture Material in Resective Periodontal Surgery
NCT058132361 location
Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)
NCT065633232 locations
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
NCT05723198127 locations